Medicina Legal, Psiquiatría y Patología
Departamento
University of Texas MD Anderson Cancer Center
Houston, Estados UnidosPublicacións en colaboración con investigadores/as de University of Texas MD Anderson Cancer Center (21)
2024
-
Optimizing tissue stewardship in non-small cell lung cancer to support molecular characterization and treatment selection: statement from a working group of thoracic pathologists
Histopathology, Vol. 84, Núm. 3, pp. 429-439
2023
-
Sperm protein antigen 17 and Sperm flagellar 1 cancer testis antigens are expressed in a rare case of ciliated foregut cyst of the common hepatic duct
Pathology Research and Practice, Vol. 247
2022
-
NSCLC Subtyping in Conventional Cytology: Results of the International Association for the Study of Lung Cancer Cytology Working Group Survey to Determine Specific Cytomorphologic Criteria for Adenocarcinoma and Squamous Cell Carcinoma
Journal of Thoracic Oncology, Vol. 17, Núm. 6, pp. 793-805
-
Predictive Biomarkers for Immunotherapy in Lung Cancer: Perspective From the International Association for the Study of Lung Cancer Pathology Committee
Journal of Thoracic Oncology, Vol. 17, Núm. 12, pp. 1335-1354
2021
-
The International Association for the Study of Lung Cancer Global Survey on Programmed Death-Ligand 1 Testing for NSCLC
Journal of Thoracic Oncology, Vol. 16, Núm. 4, pp. 686-696
2020
-
A Grading System for Invasive Pulmonary Adenocarcinoma: A Proposal From the International Association for the Study of Lung Cancer Pathology Committee
Journal of Thoracic Oncology, Vol. 15, Núm. 10, pp. 1599-1610
-
IASLC Multidisciplinary Recommendations for Pathologic Assessment of Lung Cancer Resection Specimens After Neoadjuvant Therapy
Journal of Thoracic Oncology, Vol. 15, Núm. 5, pp. 709-740
-
PD-L1 Testing for Lung Cancer in 2019: Perspective From the IASLC Pathology Committee
Journal of Thoracic Oncology, Vol. 15, Núm. 4, pp. 499-519
-
The Promises and Challenges of Tumor Mutation Burden as an Immunotherapy Biomarker: A Perspective from the International Association for the Study of Lung Cancer Pathology Committee
Journal of Thoracic Oncology, Vol. 15, Núm. 9, pp. 1409-1424
2019
-
Best Practices Recommendations for Diagnostic Immunohistochemistry in Lung Cancer
Journal of Thoracic Oncology, Vol. 14, Núm. 3, pp. 377-407
2017
-
Analysis of the mutational landscape of classic Hodgkin lymphoma identifies disease heterogeneity and potential therapeutic targets
Oncotarget, Vol. 8, Núm. 67, pp. 111386-111395
2016
-
Imaging mass spectrometry assists in the classification of diagnostically challenging atypical Spitzoid neoplasms
Journal of the American Academy of Dermatology, Vol. 75, Núm. 6, pp. 1176-1186.e4
2015
-
Cutaneous lymphoma international consortium study of outcome in advanced stages of mycosis fungoides and sézary syndrome: Effect of specific prognostic markers on survival and development of a prognostic model
Journal of Clinical Oncology, Vol. 33, Núm. 32, pp. 3766-3773
-
PET-Florbetapir findings in primary cerebral amyloidoma
Journal of Neurology
2013
-
MicroRNA signatures and treatment response in patients with advanced classical Hodgkin lymphoma
British Journal of Haematology, Vol. 162, Núm. 3, pp. 336-347
1994
-
Open quiz solution: Case report 806
Skeletal Radiology, Vol. 23, Núm. 1, pp. 55-57
1993
-
Case report 806
Skeletal Radiology, Vol. 22, Núm. 6, pp. 476
-
Open quiz: Case report 806
Skeletal Radiology, Vol. 22, Núm. 6, pp. 476
1992
-
Neurothekeoma of the oral cavity: Case report and review of the literature
Journal of Oral and Maxillofacial Surgery, Vol. 50, Núm. 11, pp. 1224-1226
-
Synovial sarcoma of the tongue: Case report and review of the literature
Journal of Oral and Maxillofacial Surgery, Vol. 50, Núm. 8, pp. 904-906